Jens De Vos

Nanobodies Targeting Mouse/Human VCAM1 for the Nuclear Imaging of Atherosclerotic Lesions

Alexis Broisat, Sophie Hernot, Jakub Toczek et al. · Circulation Research · 2012 · 192 citations · Full text

Site-Specific Labeling of Cysteine-Tagged Camelid Single-Domain Antibody-Fragments for Use in Molecular Imaging

Sam Massa, Catarina Xavier, Jens De Vos et al. · Bioconjugate Chemistry · 2014 · 174 citations

Nanomedicine, Homogeneous Tracer Population, Engineering +14

131I-labeled Anti-HER2 Camelid sdAb as a Theranostic Tool in Cancer Treatment

Matthias D’Huyvetter, Jens De Vos, Catarina Xavier et al. · Clinical Cancer Research · 2017 · 173 citations · Full text

Phase I Trial of ¹³¹I-GMIB-Anti-HER2-VHH1, a New Promising Candidate for HER2-Targeted Radionuclide Therapy in Breast Cancer Patients

Matthias D’Huyvetter, Jens De Vos, Vicky Caveliers et al. · Journal of Nuclear Medicine · 2020 · 116 citations · Full text

Breast Oncology, Healthy Subjects, Tumor Biology +18

Site-Specific Labeling of His-Tagged Nanobodies with 99mTc: A Practical Guide

Catarina Xavier, Nick Devoogdt, Sophie Hernot et al. · Methods in molecular biology · 2012 · 47 citations